MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access. Novo Nordisk's production shift raises concerns as diabetes cases rise, ...

Five plans will not make changes to their insulin coverage in 2025 ... five and eight of the nine most common ... [+] insulins. When entering a drug such as Lantus or Novolog, a pop-up box ...

The combination of intranasal insulin (INI) and the sodium-glucose cotransporter ... Metabolic and vascular disorders are ...

Diabetes is very common in people living in post-acute and long ... information on how to transition patients and residents ...

Adults with mild type 2 diabetes might improve their insulin sensitivity by following a low-carb diet, thus potentially ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress ...

"We know that GLP-1 drugs treat insulin resistance ... "After all, most age-related conditions share common underpinnings and vary only by which part of the body is affected," Osborn said.

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Semaglutide, the active ingredient in Ozempic and Wegovy, may also help lower the risk of developing Alzheimer’s disease in people living with type 2 diabetes.

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

Approximately one in 10 Americans has diabetes, with 90–95% of these cases being type 2, making it one of the most common ... with diet or medications but were not using insulin.